首页> 外文期刊>Experimental diabetes research >Antihypertriglyceridemia and Anti-Inflammatory Activities of Monascus-Fermented Dioscorea in Streptozotocin-Induced Diabetic Rats
【24h】

Antihypertriglyceridemia and Anti-Inflammatory Activities of Monascus-Fermented Dioscorea in Streptozotocin-Induced Diabetic Rats

机译:链脲佐菌素诱导的糖尿病大鼠红曲菌薯Di的抗高甘油三酸酯血症和抗炎活性。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The rice fermented by Monascus, called red mold rice (RMR), and has a long tradition in East Asia as a dietary staple. Monascus-fermented dioscorea called red mold dioscorea (RMD) contains various metabolites to perform the ability of reducing oxidative stress and anti-inflammatory response. We used Wistar rats and induced diabetes by injecting streptozotocin (STZ, 65 mg/kg i.p.). RMD was administered daily starting six weeks after disease onset. Throughout the experimental period, significantly (P < .05) lowered plasma glucose, triglyceride, cholesterol, free fatty acid and low density lipoprotein levels were observed in the RMD-treated groups. The RMD-treated diabetic rats showed higher activities of glutathione disulfide reductase, glutathione reductase, catalase and superoxide dismutase (P < .05) in the pancreas compared with the diabetic control rats. RMD also inhibited diabetes-induced elevation in the levels of interleukin (IL)-1beta, IL-6, interferon-gamma and tumor necrosis factor-alpha. Pancreatic beta-cells damaged by STZ in the RMD supplemented groups were ameliorated. The results of this study clearly demonstrated that RMD possesses several treatment-oriented properties, including the control of hyperglycemia, antioxidant effects, pancreatic beta-cell protection and anti-inflammatory effects. Considering these observations, it appears that RMD maybe a useful supplement to delay the development of diabetes and its complications.
机译:由红曲霉发酵的大米称为红霉米(RMR),在东亚作为饮食主食有着悠久的传统。红曲霉发酵的薯os被称为红霉薯((RMD),含有多种代谢产物,可以降低氧化应激和抗炎反应。我们使用Wistar大鼠并通过注射链脲佐菌素(STZ,65 mg / kg i.p.)诱发糖尿病。发病后六周开始每天给予RMD。在整个实验期间,在RMD治疗组中观察到血浆葡萄糖,甘油三酸酯,胆固醇,游离脂肪酸和低密度脂蛋白水平显着降低(P <.05)。与糖尿病对照大鼠相比,接受RMD治疗的糖尿病大鼠胰腺中的谷胱甘肽二硫键还原酶,谷胱甘肽还原酶,过氧化氢酶和超氧化物歧化酶活性更高(P <.05)。 RMD还抑制糖尿病诱导的白介素(IL)-1beta,IL-6,干扰素-γ和肿瘤坏死因子-α水平升高。 RMD补充组中STZ损伤的胰腺β细胞得到改善。这项研究的结果清楚地表明,RMD具有几种面向治疗的特性,包括控制高血糖,抗氧化作用,胰岛β细胞保护和抗炎作用。考虑到这些观察结果,RMD可能是延缓糖尿病及其并发症发展的有用补充剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号